Home Newsfeeds Wedbush Upgrades Cavco Indus to Outperform, Raises Price Target to $385

Wedbush Upgrades Cavco Indus to Outperform, Raises Price Target to $385

Wedbush analyst Jay McCanless upgrades Cavco Indus (NASDAQ:CVCO) from Neutral to Outperform and raises the price target from $315 to $385.

byBenzinga Newsdesk

August 5, 2022

1 minute read

Wedbush analyst Jay McCanless upgrades Cavco Indus (NASDAQ:CVCO) from Neutral to Outperform and raises the price target from $315 to $385.

Piper Sandler Maintains Overweight on Tyler Technologies, Lowers Price Target to $405

By Benzinga Newsdesk

July 18, 5:29 AM

Piper Sandler analyst Brent Bracelin maintains Tyler Technologies (NYSE:TYL) with a Overweight and lowers the price target from $540 to $405.

TYL

Harbor Custom Development, Inc. Announces 1-For-20 Reverse Stock Split

By Happy Mohamed

March 3, 2:01 PM

Harbor Custom Development, Inc. (NASDAQ:HCDI, HCDIP, HCDIW, HCDIZ)))) ("Harbor," "Harbor Custom Homes®," or the "Company"), an innovative real estate company involved in all aspects of

HCDI

Medtronic’s Heart Catheter Achieves Safety And Efficacy Goals In Patients With Irregular Heartbeat

By Vandana Singh

May 20, 2:22 PM

Medtronic's SPHERE Per-AF study results reveal the Sphere-9 Catheter's superior safety and efficacy in treating persistent atrial fibrillation compared to the Thermocool SmartTouch SF. The Sphere-9 offers advanced mapping and ablation, showing higher freedom from AFib and fewer complications.

MDT